| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.00▲ | 1.00▲ | 1.01▲ | 1.03▼ | 0.95▲ |
| MA10 | 1.00▲ | 1.01▲ | 1.03▼ | 1.02▼ | 0.96▲ |
| MA20 | 1.03▼ | 1.03▼ | 1.03▼ | 0.96▲ | 0.96▲ |
| MA50 | 1.03▼ | 1.02▼ | 1.01▲ | 0.98▲ | 1.66▼ |
| MA100 | 1.02▼ | 1.00▲ | 0.95▲ | 0.96▲ | 133.46▼ |
| MA200 | 0.98▲ | 0.93▲ | 0.95▲ | 1.14▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.001▼ | -0.005▼ | -0.006▼ | 0.010▲ | 22.204▲ |
| RSI | 46.183▼ | 47.171▼ | 47.537▼ | 53.282▲ | 21.211▼ |
| STOCH | 36.491 | 18.208▼ | 16.237▼ | 67.734 | 46.542 |
| WILL %R | -40.323 | -72.993 | -72.993 | -40.476 | -35.703 |
| CCI | 39.950 | -34.483 | -67.078 | 39.840 | 39.844 |
|
Monday, July 07, 2025 05:12 AM
Allarity Therapeutics, Inc. (NASDAQ: ALLR) is a clinical-stage biopharmaceutical company dedicated to developing personalized cancer treatments.
|
|
Friday, June 27, 2025 05:14 AM
Allarity Therapeutics, Inc. (NASDAQ: ALLR) is a clinical-stage biopharmaceutical company dedicated to developing personalized cancer treatments.
|
|
Thursday, May 29, 2025 06:18 AM
Allstate (NYSE:ALL) has recently announced a $1.00 per share dividend, reinforcing their commitment to shareholder value, further evidenced by last quarter’s 5% stock price increase.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 11/07/25 | 1.04 | 1.0581 | 0.9827 | 1.01 | 371,079 |
| 10/07/25 | 1.02 | 1.08 | 1.02 | 1.08 | 353,439 |
| 09/07/25 | 1.03 | 1.05 | 1.01 | 1.05 | 247,826 |
| 08/07/25 | 0.98 | 1.04 | 0.9713 | 1.03 | 342,542 |
| 07/07/25 | 0.97 | 1.00 | 0.95 | 0.9833 | 239,630 |
| 03/07/25 | 1.00 | 1.02 | 0.9784 | 1.01 | 88,581 |
| 02/07/25 | 1.04 | 1.04 | 0.9899 | 1.00 | 308,655 |
| 01/07/25 | 1.01 | 1.04 | 0.96 | 1.04 | 385,282 |
| 30/06/25 | 0.99 | 1.02 | 0.986 | 1.01 | 280,001 |
| 27/06/25 | 1.00 | 1.01 | 0.9723 | 0.9999 | 295,168 |
|
|
||||
|
|
||||
|
|